| Previous close | 12.80 |
| Open | N/A |
| Bid | 18.70 |
| Ask | 23.00 |
| Strike | 92.50 |
| Expiry date | 2024-06-21 |
| Day's range | 12.80 - 12.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Business WireGlaukos Announces Participation in Upcoming Investor Conferences
ALISO VIEJO, Calif., May 28, 2024--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:
ZacksGlaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Simply Wall St.Earnings Update: Here's Why Analysts Just Lifted Their Glaukos Corporation (NYSE:GKOS) Price Target To US$113
It's been a pretty great week for Glaukos Corporation ( NYSE:GKOS ) shareholders, with its shares surging 12% to US$108...
© 2024 Yahoo. All rights reserved.